Ji-Na Zheng
Overview
Explore the profile of Ji-Na Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yan Y, Zheng J, Wu L, Rao Q, Yang Q, Gao D, et al.
Front Genet
. 2021 Jul;
12:633059.
PMID: 34290731
Systemic sclerosis (SSc) is an immune-mediated connective tissue disease characterized by fibrosis of multi-organs, and SSc-related interstitial lung disease (SSc-ILD) is a leading cause of morbidity and mortality. To explore...
2.
3.
Li Y, Zheng J, Wang E, Gong C, Lan K, Ding X
PeerJ
. 2020 Dec;
8:e10385.
PMID: 33304653
Background: Increasing evidence has shown that N6-methyladenosine (m6A) RNA methylation regulators have important biological functions in human cancers. However, there are few studies on the value of m6A reader protein...
4.
Yan Y, Zheng J, Li Y, Yang Q, Shao W, Wang Q
Clin Exp Rheumatol
. 2020 Nov;
39 Suppl 131(4):66-76.
PMID: 33253093
Objectives: Systemic sclerosis (SSc) is an autoimmune disease clinically characterised by skin and internal organs fibrosis with high mortality. However, the pathogenesis of SSc is still controversial and the effect...
5.
Li Y, Zheng J, Wang E, Lan K, Gong C, Ding X
Arch Oral Biol
. 2020 Sep;
119:104895.
PMID: 32916454
Objective: The aim of this study was to construct a gene co-expression network to identify key modules and genes in people with generalized aggressive periodontitis. Methods: We used database GSE79705...
6.
Zheng J, Li Y, Yan Y, Shi H, Zou T, Shao W, et al.
Front Genet
. 2020 Aug;
11:816.
PMID: 32793290
Systemic sclerosis-associated with pulmonary arterial hypertension (SSc-PAH) is still a major cause of SSc related deaths. Early diagnosis and prompt treatment are crucial to reduce the mortality of patients with...
7.
Zheng J, Li Y, Yan Y, Yu Y, Shao W, Wang Q
Arthritis Res Ther
. 2020 May;
22(1):110.
PMID: 32393322
Background: Systemic sclerosis (SSc) or scleroderma is an intractable autoimmune disorder that affects multiple organs. The objectives were to investigate clinical correlations of serum calpain activity and high mobility group...
8.
Zheng J, Yang Q, Zhu G, Pan L, Xia J, Wang Q
Mod Rheumatol
. 2019 Jul;
30(4):687-695.
PMID: 31269839
Immunosuppressive therapies for the treatment of patients with systemic sclerosis (SSc) and SSc related interstitial lung diseases (SSc-ILD) include cyclophosphamide (CYC), mycophenolate mofetil (MMF), azathioprine (AZA) and methotrexate (MTX). The...
9.
Zou T, Zhou Y, Zhou X, Liu W, Van Poucke S, Wu W, et al.
Horm Metab Res
. 2018 Sep;
50(9):683-689.
PMID: 30184562
Although several risk factors for metabolic syndrome (MetS) have been reported, there are few clinical scores that predict its incidence. Therefore, we created and validated a risk score for prediction...
10.
Zhou Y, Zhou Y, Zheng J, Liu W, Van Poucke S, Zou T, et al.
Clin Chim Acta
. 2017 Oct;
475:44-50.
PMID: 28964832
Background: Several non-invasive diagnostic scores for non-alcoholic fatty liver (NAFL) have been developed, but the clinical application is limited because of their complexity. Aim: To develop and validate an easy-to-calculate...